Zhenyu Zhou1, Lei Gong1, Xiaoyun Wang2, Zhen Hu1, Gaojue Wu1, Xuejun Tang1, Xiaobin Peng1, Shuan Tang1, Miao Meng1, Hui Feng1. 1. Division of Gastroenterology, Wuxi No.2 Hospital Affiliated with Nanjing Medical University, Zhong Shan Road 68, Wuxi, Jiang Su Province, China. 2. Division of Gastroenterology, Wuxi No.2 Hospital Affiliated with Nanjing Medical University, Zhong Shan Road 68, Wuxi, Jiang Su Province, China. xiaoyunwang68@aliyun.com.
Abstract
INTRODUCTION: The past decade has provided striking insights into a newly identified subset of B cells known as regulatory B cells (Bregs). In addition to producing antibody, Bregs also regulate diseases via cytokine production and antigen presentation. This subset of B cells has protective and potentially therapeutic effects. However, the particularity of Bregs has caused some difficulties in conducting research on their roles. Notably, human B10 cells, which are Bregs that produce interleukin 10, share phenotypic characteristics with other previously defined B cell subsets, and currently, there is no known surface phenotype that is unique to B10 cells. METHODS: An online search was performed in the PubMed and Web of Science databases for articles published providing evidences on the role of regulatory B cells in digestive system diseases. RESULTS AND CONCLUSIONS: Abundant evidence has demonstrated that Bregs play a regulatory role in inflammatory, autoimmune, and tumor diseases, and regulatory B cells play different roles in different diseases, but future work needs to determine the mechanisms by which Bregs are activated and how these cells affect their target cells.
INTRODUCTION: The past decade has provided striking insights into a newly identified subset of B cells known as regulatory B cells (Bregs). In addition to producing antibody, Bregs also regulate diseases via cytokine production and antigen presentation. This subset of B cells has protective and potentially therapeutic effects. However, the particularity of Bregs has caused some difficulties in conducting research on their roles. Notably, human B10 cells, which are Bregs that produce interleukin 10, share phenotypic characteristics with other previously defined B cell subsets, and currently, there is no known surface phenotype that is unique to B10 cells. METHODS: An online search was performed in the PubMed and Web of Science databases for articles published providing evidences on the role of regulatory B cells in digestive system diseases. RESULTS AND CONCLUSIONS: Abundant evidence has demonstrated that Bregs play a regulatory role in inflammatory, autoimmune, and tumor diseases, and regulatory B cells play different roles in different diseases, but future work needs to determine the mechanisms by which Bregs are activated and how these cells affect their target cells.
Entities:
Keywords:
Adaptive immunity; Digestive system diseases; IL-10; Regulatory B cells
Authors: Thomas Calzascia; Marc Pellegrini; Håkan Hall; Laurent Sabbagh; Nobuyuki Ono; Alisha R Elford; Tak W Mak; Pamela S Ohashi Journal: J Clin Invest Date: 2007-12 Impact factor: 14.808
Authors: Paul A Blair; Lina Yassin Noreña; Fabian Flores-Borja; David J Rawlings; David A Isenberg; Michael R Ehrenstein; Claudia Mauri Journal: Immunity Date: 2010-01-14 Impact factor: 31.745
Authors: Tiziana Schioppa; Robert Moore; Richard G Thompson; Elizabeth C Rosser; Hagen Kulbe; Sergei Nedospasov; Claudia Mauri; Lisa M Coussens; Frances R Balkwill Journal: Proc Natl Acad Sci U S A Date: 2011-06-13 Impact factor: 11.205